These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30782874)

  • 21. A Monte Carlo tool to simulate breast cancer screening programmes.
    Forastero C; Zamora LI; Guirado D; Lallena AM
    Phys Med Biol; 2010 Sep; 55(17):5213-29. PubMed ID: 20714045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Monte Carlo analysis of breast screening randomized trials.
    Zamora LI; Forastero C; Guirado D; Lallena AM
    Phys Med; 2016 Dec; 32(12):1609-1614. PubMed ID: 27914780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of Overdiagnosis: Impact on Screening Mammography Practices.
    Morris E; Feig SA; Drexler M; Lehman C
    Popul Health Manag; 2015 Sep; 18 Suppl 1(Suppl 1):S3-11. PubMed ID: 26414384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overdiagnosis in mammography screening].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2004 Sep; 124(17):2238-9. PubMed ID: 15356688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer biology varies by method of detection and may contribute to overdiagnosis.
    Hayse B; Hooley RJ; Killelea BK; Horowitz NR; Chagpar AB; Lannin DR
    Surgery; 2016 Aug; 160(2):454-62. PubMed ID: 27241117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
    Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
    Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data.
    Seigneurin A; François O; Labarère J; Oudeville P; Monlong J; Colonna M
    BMJ; 2011 Nov; 343():d7017. PubMed ID: 22113564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
    Bleyer A
    Acad Radiol; 2015 Aug; 22(8):949-60. PubMed ID: 26100188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
    Hellquist BN; Duffy SW; Nyström L; Jonsson H
    J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.
    Jørgensen KJ; Gøtzsche PC
    BMJ; 2009 Jul; 339():b2587. PubMed ID: 19589821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpreting overdiagnosis estimates in population-based mammography screening.
    de Gelder R; Heijnsdijk EA; van Ravesteyn NT; Fracheboud J; Draisma G; de Koning HJ
    Epidemiol Rev; 2011; 33(1):111-21. PubMed ID: 21709144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    Monticciolo DL; Helvie MA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C; Pompei F; Burmistrov D; Wilson R
    Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.